Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.7485
+0.04246.00%
Post-market: 0.75000.0015+0.20%19:58 EDT
Volume:3.66M
Turnover:2.68M
Market Cap:41.89M
PE:-1.17
High:0.7502
Open:0.7150
Low:0.7090
Close:0.7061
52wk High:1.55
52wk Low:0.1952
Shares:55.97M
Float Shares:55.97M
Volume Ratio:0.96
T/O Rate:6.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6401
EPS(LYR):-0.7437
ROE:-543.97%
ROA:-70.59%
PB:-11.70
PE(LYR):-1.01

Loading ...

New fund name, ASX code, investment manager and PDS-V1A

Reuters
·
Jun 05

New Issue 175 Single Stock MINIs Issue Date 4 Jun 26 PDS-CTW

Reuters
·
Jun 03

PDS Biotech regains Nasdaq compliance after shares close above $1 bid threshold

Reuters
·
Jun 03

Lion Active ETF - PDS-ROA

Reuters
·
Jun 01

CitiFirst Commodity MINIs Issue Date 27 May 2026 PDS-CTW

Reuters
·
May 26

PDS Biotechnology Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Analysts’ Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)

TIPRANKS
·
May 13

PDS Biotechnology Q1 net loss narrows

Reuters
·
May 13

PDS Biotechnology Q1 EPS USD -0.13

THOMSON REUTERS
·
May 13

PDS Biotechnology Q1 Net Income USD -7.3 Million

THOMSON REUTERS
·
May 13

PDS Biotechnology Corp expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
May 11

Platinum Active ETFs SPDS and Platinum Trust PDS-PAX

Reuters
·
May 11

PDS Biotech schedules first-quarter results conference call, webcast

Reuters
·
May 06

PDS Biotech signs USD 6 million promissory note financing with YA II PN

Reuters
·
May 02

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Analysts’ Top Healthcare Picks: PTC Therapeutics (PTCT), PDS Biotechnology (PDSB)

TIPRANKS
·
Apr 16

PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC

TIPRANKS
·
Apr 15

BUZZ-PDS Biotech jumps on early data for experimental colon cancer drug

Reuters
·
Apr 15

PDS Biotech reports 78% response rate in interim Phase 2 colorectal cancer trial

Reuters
·
Apr 15

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data From Stage 1 of Nci-Led Metastatic Colorectal Cancer (Mcrc) Trial

THOMSON REUTERS
·
Apr 15